Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Array BioPharma

Array BioPharma
1998 FOUNDED
PRIVATE STATUS
201-300 EMPLOYEES
M&A LATEST DEAL TYPE
$11.4B LATEST DEAL AMOUNT
4 INVESTORS
Description

Array BioPharma Inc is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Its clinical stage drugs include Binimetinib, Encorafenib, Selumetinib, Tucatinib/ONT-380, ARRY-382, LOXO-292 and LOXO-195 among others. The company has geographical presence in North America, Europe and Asia Pacific.

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 3200 Walnut Street
  • Boulder, CO 80301
  • United States

+1 (303) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Array BioPharma’s full profile, request a free trial.

Array BioPharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 30-Jul-2019 $11.4B 00000 000.00 Completed Profitable
8. PIPE 10-Jun-2013 00000 00000 Completed Generating Revenue
7. PIPE 02-May-2011 0000 00000 Completed Generating Revenue
6. Debt - General 19-May-2009 0000 00000 Completed Generating Revenue
5. Debt - General 23-Dec-2008 0000 00000 Completed Generating Revenue
4. IPO 17-Nov-2000 000.00 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 31-Aug-2000 0000 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 16-Nov-1999 $8M $14.6M 000.00 Completed Startup
1. Early Stage VC (Series A) 15-Jan-1999 $6.6M $6.6M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Array BioPharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00 00 00 00 0.000
Series B 0,000,000 00.0 00.0 00 00.0 00.000
Series A 6,800,000 $1 $1 1x $1 33.62%
To view this company’s complete Cap Table, request access »

Array BioPharma Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Molecular Partners Formerly VC-backed Zurich, Switzerland 000 00000 00000000000 00000
00000000 Angel-Backed Culver City, CA 00000 000000000000 00000
000000000 Private Equity-Backed Camarillo, CA 00 000 00 000000 000
000000 Venture Capital-Backed Cambridge, United Kingdom 00 0000 000000 - 000 0000
00000 Formerly VC-backed Cambridge, MA 000 00000 0&0
To view this company’s complete list of competitors, request access »

Array BioPharma Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000 (0 02-Mar-2015 000000000 00000 00 Other Business Products and Services 000 0000000
Loxo Oncology Early Stage VC Pharmaceuticals
To view this company’s complete investment and acquisition history, request access »

Array BioPharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 00000000 00000 00000 00 Completed
  • 2 buyers
To view this company’s complete exits history, request access »

Array BioPharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Ridgeback Capital Other Minority 000 0000 000000 0
Deerfield Management Venture Capital Minority 000 0000 000000 0
Mosaix Ventures Venture Capital Minority 000 0000 000000 0
Synthesis Capital Venture Capital Minority 000 0000 000000 0

Array BioPharma Executive Team (44)

Name Title Board
Seat
Contact
Info
Robert Conway Chief Executive Officer & Board Member
Ron Squarer Chief Executive Officer
Jason Haddock Chief Financial Officer & Chief Accounting Officer
David Snitman Ph.D Co-Founder, Chief Operating Officer & Vice President of Business Development
Andrew Robbins Chief Operating Officer

23 Former Executives

You’re viewing 5 of 44 executives. Get the full list »

Array BioPharma Board Members (15)

Name Representing Role Since Contact
Info
Gil Van Lunsen Self Board Member 000 0000
John Zabriskie Ph.D Array BioPharma Board Member 000 0000
Liam Ratcliffe Ph.D Self Board Member 000 0000
Robert Conway Array BioPharma Chief Executive Officer & Board Member 000 0000

11 Former Board Members

You’re viewing 4 of 15 board members. Get the full list »